Target intelligence / Profile preview

Gastric acid and gastric contents

Molecular classification
Inorganic compound, Other
01

Overview

Gastric acid, primarily composed of hydrochloric acid (HCl), is a digestive fluid produced by the parietal cells in the gastric glands of the stomach (StatPearls, NBK535425). Its primary biological roles include the denaturation of proteins, the conversion of pepsinogen to the active protease pepsin, and acting as a first-line immune defense by neutralizing ingested pathogens (NIH, PubChem CID 313). While essential for normal digestion, the presence of gastric acid and the reflux of gastric contents into the esophagus are central to the pathophysiology of gastroesophageal reflux disease (GERD), gastritis, and peptic ulcer disease (StatPearls, NBK526049). In pharmacology, gastric acid is a direct therapeutic target for antacids, which are weak bases that react chemically to neutralize HCl, thereby increasing gastric pH and reducing mucosal irritation. Additionally, gastric contents are targeted by alginates, which react with acid to form a physical raft or barrier that floats on the stomach contents to prevent reflux (StatPearls, NBK526049). Unlike systemic drugs like proton pump inhibitors that inhibit acid production at the cellular level, agents targeting gastric acid and contents act locally within the stomach lumen to provide rapid symptomatic relief.

Other names
Gastric juiceStomach acidGastric secretionsHydrochloric acidGastric chyme
02

Mechanism of action

Direct chemical neutralization of hydrochloric acid to increase gastric pH; physical barrier (raft) formation to prevent esophageal reflux; formation of a protective polyanionic paste that binds to ulcerated mucosa.

03

Biological functions

DigestionProtein denaturationAntimicrobial defenseEnzyme activationVitamin B12 absorption support
04

Disease associations

Gastroesophageal reflux diseasePeptic ulcer diseaseGastritisDyspepsiaZollinger-Ellison syndromeLaryngopharyngeal reflux
05

Safety considerations

Acid rebound effectMilk-alkali syndromeElectrolyte imbalance (hypermagnesemia, hypercalcemia)Altered absorption of pH-dependent drugsConstipationDiarrheaAluminum toxicity in renal impairment
06

Interacting drugs

Aluminum hydroxide

6 more in the full profile.

07

Biomarkers

Gastric pHGastrin levelsPepsin activityEsophageal pH monitoring

Beyond the preview

Go deeper on Gastric acid and gastric contents.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric acid and gastric contents.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call